174 related articles for article (PubMed ID: 32199031)
21. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
22. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
[TBL] [Abstract][Full Text] [Related]
24. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
Kim MS; Malik NH; Chen H; Poon I; Husain Z; Eskander A; Boldt G; Louie AV; Karam I
Head Neck; 2022 Mar; 44(3):770-782. PubMed ID: 34927313
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
Delerue C; Pasquier D; Bogart E; Mirabel X; Laffarguette J; Lals S; Barthoulot M; Lartigau E; Liem X
Radiother Oncol; 2024 Jan; 190():110029. PubMed ID: 38007041
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.
Vargo JA; Wegner RE; Heron DE; Ferris RL; Rwigema JC; Quinn A; Gigliotti P; Ohr J; Kubicek GJ; Burton S
Head Neck; 2012 Aug; 34(8):1153-61. PubMed ID: 22076812
[TBL] [Abstract][Full Text] [Related]
28. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
Pasalic D; Betancourt-Cuellar SL; Taku N; Ludmir EB; Lu Y; Allen PK; Tang C; Antonoff MB; Fuller CD; Rosenthal DI; Morrison WH; Phan J; Garden AS; Welsh JW; Chang JY; Liao Z; Erasmus JJ; Nguyen QN
Head Neck; 2020 Aug; 42(8):1939-1953. PubMed ID: 32129548
[TBL] [Abstract][Full Text] [Related]
29. [Re-irradiation with SBRT (Stereotactic Body Radiation Therapy) for locoregional unresectable relapse of head and neck cancer: a case report].
Flamarique S; Campo M; Asín G; Zubimendi C; Arias F
An Sist Sanit Navar; 2019 Dec; 42(3):339-343. PubMed ID: 31343640
[TBL] [Abstract][Full Text] [Related]
30. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
31. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Diao K; Nguyen TP; Moreno AC; Reddy JP; Garden AS; Wang CH; Tung S; Wang C; Wang XA; Rosenthal DI; Fuller CD; Gunn GB; Frank SJ; Morrison WH; Shah SJ; Lee A; Spiotto MT; Su SY; Ferrarotto R; Phan J
Head Neck; 2021 Nov; 43(11):3331-3344. PubMed ID: 34269492
[TBL] [Abstract][Full Text] [Related]
35. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
37. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: When less is enough.
Swain M; Ghosh-Laskar S
Oral Oncol; 2021 May; 116():105265. PubMed ID: 33770592
[TBL] [Abstract][Full Text] [Related]
39. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
Karam I; Yao M; Heron DE; Poon I; Koyfman SA; Yom SS; Siddiqui F; Lartigau E; Cengiz M; Yamazaki H; Hara W; Phan J; Vargo JA; Lee V; Foote RL; Harter KW; Lee NY; Sahgal A; Lo SS
Future Oncol; 2017 Mar; 13(7):603-613. PubMed ID: 27842456
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer.
Vargo JA; Ferris RL; Clump DA; Heron DE
Front Oncol; 2014; 4():214. PubMed ID: 25157336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
